|
End-of-day quote
Korea S.E.
2026-10-20
|
5-day change | 1st Jan Change | ||
| 2,600.00 KRW | -0.95% |
|
-5.11% | -44.50% |
| 09-20 | Genexine, Inc.(KOSDAQ:A095700) dropped from S&P Global BMI Index | CI |
| 09-15 | Genexine Presents Preclinical Data For GX-BP1 SOX2 BioPROTAC At 2026 World Conference On Lung Cancer | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 89.65M | - | - | - | - | - |
| 65.83B | |||||
| 51.87B | |||||
| 51.2B | |||||
| 43.76B | |||||
| 42.09B |
- Stock Market
- Stocks
- A095700 Stock
- Charts Genexine, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
